LBA15 Primary results from IMpassion131, a double-blind...

LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)

Miles, D.W., Gligorov, J., André, F., Cameron, D., Schneeweiss, A., Barrios, C.H., Xu, B., Wardley, A.M., Kaen, D., Andrade, L., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Russell, K., Don
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.2243
Date:
September, 2020
File:
PDF, 117 KB
2020
Conversion to is in progress
Conversion to is failed